Accelerate to discover
Related topics
High-frequency Ultrasound System For Preclinical Imaging
May 13, 2024
The Prospect T1 is an innovative high-frequency ultrasound system designed specifically for in vivo preclinical imaging...
“Range+T “ for Tight Sizing of HMW Libraries
May 10, 2024
We decided to do a deep dive into Range+T to get a better handle the method, and to develop best practices for using...
April 2024 publication revealing benefits of using intravital microscopy in trascriptomics studies
May 8, 2024
Transcriptional activation of Bmal1 drives the inflammatory activity of monocytes by modulating mitochondrial unfolded...
Minimal information for studies of extracellular vesicles (MISEV2023)
May 7, 2024
MISEV2023 is intended to aid any and all EV researchers: from those just starting their EV journey to more established...
Omics Studies of Tumor Cells under Microgravity Conditions
May 6, 2024
It is important for the analysis of data from space experiments to distinguish unspecific stress reactions from...
Column-Free CD14+ Monocyte Isolation using 50nm Superparamagentic Beads on MARS® Bar
Apr 25, 2024
The MARS® Bar Magnetic Separation Platform is a closed and automated isolation for cell therapy development and...
Spatial and temporal profiling of the complement system uncovered novel functions of the alternative
Apr 24, 2024
Mounting evidence implicated the classical complement pathway (CP) in normal brain development, and the pathogenesis of...
The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging
Apr 4, 2024
Here, we assessed the chicken chorioallantoic membrane (CAM) as an alternative to mice for preclinical cancer imaging...
Jul 11, 2018
Cancer stem cells (CSCs) are a very rare type of cells which causes metastasis in breast cancer. Their resistance to existing therapies makes effective treatment of breast cancer in later stages very difficult. Here researchers from Cardiff University did a study on their relationship with δT cells and CD8+ T cells to help develop new treatments.
The CSCs are developed with epithelial-to-mesenchymal transition (EMT) and judged based on the CD44 hi/lo phenotype. With these cells, an immunotherapy treatment can be tested with expanded or genetically engineered T cells.
The researchers have found a synergism between γδT cells and CD8+T cells in the eradication of CSCs cells. This suggests that an approach with the combination of MHC-restricted and non-MHC-restricted may be beneficial for breast cancer patients. The paper also offers an interesting and useful tool to study CSC cells.
Related technologies: Live cell imaging
Brand profile
With a focus on portability, ease of use, high-quality imaging and fast frame-rate, Etaluma developed new concept in simple, affordable, and accessible fluorescence microscopy.
More info at:
www.etaluma.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
